Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-007152
Filing Date
2011-08-09
Accepted
2011-08-09 16:06:37
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2205174z10-q.htm 10-Q 435092
2 EX-3.1 a2205174zex-3_1.htm EX-3.1 128431
3 EX-31.1 a2205174zex-31_1.htm EX-31.1 8623
4 EX-31.2 a2205174zex-31_2.htm EX-31.2 8631
5 EX-32.1 a2205174zex-32_1.htm EX-32.1 9458
  Complete submission text file 0001047469-11-007152.txt   2039386

Data Files

Seq Description Document Type Size
6 EX-101.INS supg-20110630.xml EX-101.INS 178941
7 EX-101.SCH supg-20110630.xsd EX-101.SCH 14507
8 EX-101.CAL supg-20110630_cal.xml EX-101.CAL 34215
9 EX-101.DEF supg-20110630_def.xml EX-101.DEF 61002
10 EX-101.LAB supg-20110630_lab.xml EX-101.LAB 205148
11 EX-101.PRE supg-20110630_pre.xml EX-101.PRE 97947
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
SUPERGEN INC (Filer) CIK: 0000919722 (see all company filings)

EIN.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27628 | Film No.: 111020843
SIC: 2834 Pharmaceutical Preparations